Literature DB >> 6337569

Early assessment of rest and exercise left ventricular function following coronary artery surgery.

E H Austin, H N Oldham, D C Sabiston, R H Jones.   

Abstract

Radionuclide assessment of rest and exercise left ventricular function was performed in 14 patients before, eight days after, and three months after coronary artery bypass grafting (CABG). Resting function was unaltered after operation, although mild increases in heart rate and end-diastolic volume were observed on the eighth postoperative day. In contrast, exercise function was significantly improved at both postoperative time periods. Exercise ejection fraction was 0.54 +/- 0.10 before operation, 0.73 +/- 0.12 at eight days, and 0.64 +/- 0.13 at three months. Before CABG, the exercise-induced increase in stroke volume was achieved by an increase in end-diastolic volume, whereas eight days after CABG this increase was achieved by an increase in contractility (systolic blood pressure/end-systolic volume). By three months, both contractility and end-diastolic volume increased with exercise. Thus, improvement in left ventricular function during exercise can be documented as early as eight days after coronary revascularization. This change may be less pronounced after three months of convalescence, but considerable improvement in ventricular function persists compared to preoperative assessment.

Entities:  

Mesh:

Year:  1983        PMID: 6337569     DOI: 10.1016/s0003-4975(10)61454-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  [Improved regional myocardial function after aortocoronary bypass surgery noninvasive studies using the first-pass technic].

Authors:  W Hemmer; N Schad; A Markewitz; M Chiavolella; B Reichart
Journal:  Langenbecks Arch Chir       Date:  1986

2.  Risk stratification in the elderly patient after coronary artery bypass grafting: the prognostic value of radionuclide cineangiography.

Authors:  P G Supino; J B Wallis; G Chlouverakis; J S Borer
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.